Abstract

Lung cancer is the most devastating malignancy in the world. Beyond genetic research, epigenomic studies—especially investigations of microRNAs—have grown rapidly in quantity and quality in the past decade. This has enriched our understanding about basic cancer biology and lit up the opportunities for potential therapeutic development. In this review, we summarize the involvement of microRNAs in lung cancer carcinogenesis and behavior, by illustrating the relationship to each cancer hallmark capability, and in addition, we briefly describe the clinical applications of microRNAs in lung cancer diagnosis and prognosis. Finally, we discuss the potential therapeutic use of microRNAs in lung cancer.

Highlights

  • Lung cancer is the leading cause of cancer deaths worldwide

  • The miR-200 family is the best-known example to be involved in this process. miR-200 targets zinc finger E-box-binding homeobox (ZEB)1 and ZEB2, which code for the transcriptional repressors of E-cadherin

  • The downregulation of miR-144 in lung cancer cells may upregulate the glucose transporter (GLUT1) expression and increase glucose uptake [56]. miR-33b negatively regulates lactate dehydrogenase A (LDHA), an enzyme needed in glucose metabolism, and inhibits non-small-cell lung cancer (NSCLC) cell growth [57]

Read more

Summary

Introduction

Lung cancer is the leading cause of cancer deaths worldwide. In the GLOBOCAN 2018 database, 2.09 million new cases and 1.76 million deaths from lung cancers are estimated [1]. The miRNA precursors, pri-miRNAs, are large miRNAs (>100 nucleotides in length) transcribed by RNA polymerase II and subsequently processed, intranuclearly, by the RNase III enzyme, Drosha, and the double-stranded RNA (dsRNA)-binding protein, Pasha ( known as DiGeorge Syndrome critical region gene 8, DGCR8) [8]. The product of this process is called pre-miRNA, with a length of ~70 nucleotides. The pre-miRNAs are transported into cytoplasm by a RanGTP-dependent dsRNA-binding protein, exportin 5 [9] In the cytoplasm, another RNase III enzyme, Dicer, processes the pre-miRNAs into the miRNA:miRNA duplex of ~22 nucleotides. MiRNAs play a key role in genomic and epigenomic interaction [14]

The Role of miRNA in Lung Cancer Development and Behavior
Sustaining Proliferative Signaling
Evading Growth Suppressors
Enabling Replicative Immortality
Activating Invasion and Metastasis
Inducing Angiogenesis
Deregulating Cellular Energetics
Avoiding Immune Destruction and Tumors Promoting Inflammation
Genome Instability and Mutation
MicroRNA and Tumor Microenvironment
Tumor-Associated Macrophages
Tumor-Associated Fibroblasts
Tumor Endothelial Cells and Tumor-Associated Angiogenesis
The Epithelial-To-Mesenchymal Transition
The Role of miRNAs in Lung Cancer Diagnosis
Distinguishing Primary from Metastatic Tumors
Lung Cancer Screen
The Role of miRNAs in Lung Cancer Prognosis
Chemotherapy
Molecular Targeted Therapy
ALK-TKI
Immunotherapy
Current Limitations and Future Perspectives
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.